4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-22-024871
Executive Chair sold 600,000 shares at an average $99.86 ($59,914,706)
- Executive Chair gave 5,630 shares (gift)
- Executive Chair acquired 600,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
FRAZIER KENNETH C · Executive Chair
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-01 | Exercise or conversion : show line 1 in the form | +300,000 | 1,006,283.06 | D | ||
| 2022-11-01 | Sale : show line 2 in the form | −202,319 | $99.61 | $20,152,287 | 803,964.06 | D |
| 2022-11-01 | Sale : show line 3 in the form | −96,981 | $100.22 | $9,719,843 | 706,983.06 | D |
| 2022-11-01 | Sale : show line 4 in the form | −700 | $101.05 | $70,733 | 706,283.06 | D |
| 2022-11-01 | Gift : show line 5 in the form | −1,710 | 704,573.06 | D | ||
| 2022-11-01 | Gift : show line 6 in the form | −2,450 | 702,123.06 | D | ||
| 2022-11-01 | Gift : show line 7 in the form | −1,470 | 700,653.06 | D | ||
| 2022-11-02 | Exercise or conversion : show line 8 in the form | +165,828 | 866,481.06 | D | ||
| Open-market sales · 600,000 sh · avg $99.86 · $59,914,706 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-01 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −300,000 | 165,828 | D |
| 2022-11-02 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −165,828 | 0 | D |
| 2022-11-02 | Exercise or conversion : show line 14 in the form Stock Option (Right to Buy) | −134,172 | 705,769 | D |
Loading xslF345X03/form4.xml…